Suppr超能文献

lncRNA MEG3的过表达通过吸附miR-205-5p抑制卵巢癌细胞的活力和侵袭并促进其凋亡。

The overexpression of lncRNA MEG3 inhibits cell viability and invasion and promotes apoptosis in ovarian cancer by sponging miR-205-5p.

作者信息

Tao Pingping, Yang Binlie, Zhang Huiya, Sun Liyan, Wang Yungen, Zheng Weiping

机构信息

Department of Obstetrics and Gynecology, Pudong New Area People's Hospital Affiliated to Shanghai Health University No. 490, Chuanhuan South Road, Pudong New District, Shanghai, China.

Department of Gynecology, Shaoxing People's Hospital, Shaoxing Hospital, Zhejiang University, School of Medicine No. 568 Zhongxing North Road, Yuecheng District, Shaoxing 201299, Zhejiang, China.

出版信息

Int J Clin Exp Pathol. 2020 May 1;13(5):869-879. eCollection 2020.

Abstract

PURPOSE

Ovarian cancer is a common and fatal cancer in women. The long non-coding RNA (lncRNA) MEG3 was reported to affect the cellular processes of ovarian cancer, but the mechanisms remain unclear. Here, we aimed to explore the potential regulatory mechanism of MEG3 in ovarian cancer.

MATERIALS AND METHODS

A reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was conducted to analyze the expression levels of MEG3 and miR-205-5p in tissues and cell lines. An MTT assay was utilized to determine the cell viability of ovarian cancer SKOV-3 and OVCAR-8 cells. A flow cytometry analysis was employed to disclose the ovarian cancer cell apoptosis. The migration and invasion of SKOV-3 and OVCAR-8 cells were examined using a Transwell assay. A bioinformatics analysis indicated miR-205-5p as a direct target of MEG3, and a luciferase reporter assay was conducted to validate the interaction between MEG3 and miR-205-5p.

RESULTS

MEG3 was significantly down-regulated, while miR-205-5p was up-regulated in ovarian cancer tissues and cell lines. The overexpression of MEG3 and the knockdown of miR-205-5p inhibited cell viability, migration and invasion but promoted the apoptosis rate in ovarian cancer cells. MiR-205-5p was identified as a downstream gene of MEG3 and is negatively regulated by MEG3. The introduction of miR-205-5p reversed the up-regulation of MEG3-mediated suppression effects on cell viability, migration and invasion and increased cell apoptosis in ovarian cancer cells.

CONCLUSION

The overexpression of lncRNA MEG3 inhibits cell proliferation and cell invasion and promotes apoptosis in ovarian cancer by sponging miR-205-5p.

摘要

目的

卵巢癌是女性常见的致命性癌症。据报道,长链非编码RNA(lncRNA)MEG3会影响卵巢癌的细胞进程,但其机制尚不清楚。在此,我们旨在探究MEG3在卵巢癌中的潜在调控机制。

材料与方法

采用逆转录定量聚合酶链反应(RT-qPCR)分析组织和细胞系中MEG3和miR-205-5p的表达水平。利用MTT法测定卵巢癌SKOV-3和OVCAR-8细胞的细胞活力。采用流式细胞术分析揭示卵巢癌细胞凋亡情况。使用Transwell实验检测SKOV-3和OVCAR-8细胞的迁移和侵袭能力。生物信息学分析表明miR-205-5p是MEG3的直接靶点,并进行荧光素酶报告基因实验以验证MEG3与miR-205-5p之间的相互作用。

结果

在卵巢癌组织和细胞系中,MEG3显著下调,而miR-205-5p上调。MEG3的过表达和miR-205-5p的敲低抑制了卵巢癌细胞的细胞活力、迁移和侵袭,但提高了细胞凋亡率。miR-205-5p被鉴定为MEG3的下游基因,并受到MEG3的负调控。miR-205-5p的导入逆转了MEG3介导的对细胞活力、迁移和侵袭的抑制作用的上调,并增加了卵巢癌细胞的凋亡。

结论

lncRNA MEG3的过表达通过吸附miR-205-5p抑制卵巢癌细胞增殖和侵袭并促进其凋亡。

相似文献

2
lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
J Cell Biochem. 2019 Oct;120(10):17709-17722. doi: 10.1002/jcb.29037. Epub 2019 Jun 3.
3
4
LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
J Cell Physiol. 2019 Aug;234(8):13464-13480. doi: 10.1002/jcp.28026. Epub 2019 Jan 9.
6
lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Braz J Med Biol Res. 2019;52(10):e8631. doi: 10.1590/1414-431X20198631. Epub 2019 Sep 16.
7
Long non-coding RNA HOTAIR promotes cell viability, migration and invasion in thyroid cancer cells by sponging miR-17-5p.
Neoplasma. 2020 Mar;67(2):229-237. doi: 10.4149/neo_2019_190310N208. Epub 2019 Oct 8.
8
LncRNA MEG3 Protects Chondrocytes From IL-1β-Induced Inflammation Regulating miR-9-5p/KLF4 Axis.
Front Physiol. 2021 Mar 11;12:617654. doi: 10.3389/fphys.2021.617654. eCollection 2021.
9
MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Int J Mol Med. 2018 Mar;41(3):1740-1748. doi: 10.3892/ijmm.2018.3358. Epub 2018 Jan 2.
10
LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.
Transl Cancer Res. 2020 Feb;9(2):958-971. doi: 10.21037/tcr.2019.12.41.

引用本文的文献

1
LncRNAs signatures in gynecological cancers: ovarian and endometrial cancers.
Clin Transl Oncol. 2025 Aug 11. doi: 10.1007/s12094-025-04020-x.
2
Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers.
Front Oncol. 2025 Apr 2;15:1519103. doi: 10.3389/fonc.2025.1519103. eCollection 2025.
4
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications.
Cancers (Basel). 2025 Jan 30;17(3):472. doi: 10.3390/cancers17030472.
5
Mechanisms of apoptosis-related non-coding RNAs in ovarian cancer: a narrative review.
Apoptosis. 2025 Apr;30(3-4):553-578. doi: 10.1007/s10495-024-02074-w. Epub 2025 Jan 20.
6
A Comprehensive Bioinformatic Analysis Identifies a Tumor Suppressor Landscape of the MEG3 lncRNA in Breast Cancer.
Indian J Surg Oncol. 2024 Dec;15(4):752-761. doi: 10.1007/s13193-024-01992-0. Epub 2024 Jun 27.
8
Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma.
Reprod Med Biol. 2024 Apr 3;23(1):e12572. doi: 10.1002/rmb2.12572. eCollection 2024 Jan-Dec.
9
A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers.
Front Cell Dev Biol. 2022 Dec 5;10:997633. doi: 10.3389/fcell.2022.997633. eCollection 2022.
10
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases.
Front Pharmacol. 2022 Nov 29;13:1045501. doi: 10.3389/fphar.2022.1045501. eCollection 2022.

本文引用的文献

1
LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
J Cell Mol Med. 2019 Jan;23(1):29-38. doi: 10.1111/jcmm.13658. Epub 2018 Nov 22.
2
LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8127-8134. doi: 10.26355/eurrev_201812_16504.
3
Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer.
J Cell Physiol. 2019 Jul;234(7):10800-10808. doi: 10.1002/jcp.27903. Epub 2018 Dec 7.
4
Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1.
Cancer Biol Ther. 2018;19(11):1039-1056. doi: 10.1080/15384047.2018.1480279. Epub 2018 Nov 21.
6
MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Arch Biochem Biophys. 2019 Jan;661:22-30. doi: 10.1016/j.abb.2018.10.021. Epub 2018 Oct 31.
7
LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN.
Inflamm Res. 2018 Dec;67(11-12):927-936. doi: 10.1007/s00011-018-1186-z. Epub 2018 Oct 11.
8
Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
J Neurooncol. 2018 Nov;140(2):281-288. doi: 10.1007/s11060-018-2874-9. Epub 2018 Oct 3.
10
High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p.
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5938-5945. doi: 10.26355/eurrev_201809_15923.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验